Lisata Therapeutics, Inc. (LSTA) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Lysetta Therapeutics Second Quarter 2025 Financial Results and Business Update Conference Call. Currently, all participants are in the listen-only mode. Following management's prepared remarks, we will hold a Q&A session. To ask a question at the time, please press star 11 on your telephone. You will then hear an automated message advising a hand is raised. As a reminder, this call is being recorded today, Thursday, August 7, 2025. I will now turn the call over to John Mendito, Vice President of Investor Relations and Corporate Communications at Lesada. Please go ahead, sir. Thank you, Operator, and good afternoon, everyone. For those of you who have been on Lesada's calls previously, you'll recognize that this is not John Mendito speaking, but this is actually the President and Chief Executive Officer, David Mazzo. Unfortunately, John is having technical difficulties and hasn't been able to join the call, and some of the other speakers have also been having some issues today, so we apologize for any inconsistent sound, and we hope that you'll be able to hear the webcast at a later date. Joining me from the management team are Dr. Kristen Buck, the Executive Vice President of Research and Development and Chief Medical Officer, and James Nisko, Senior Vice President of Finance and Treasury and Chief Accounting Officer. Shortly before this call, we issued a press release announcing our second quarter 2025 financial results, which is available under the Investors and News section of the company website, along with a webcast replay of this call. If you have not received this news release or if you would like to be added to the company's email distribution list, please subscribe to email alerts on the company website or email John Mendito at jmendito, M-E-N...